Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Dr Reddys Laboratories (RDY) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • Dr Reddys Laboratories' Share-based Compensation fell 1027.95% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 724.07%. This contributed to the annual value of $5.0 million for FY2025, which is 0.0% changed from last year.
  • Dr Reddys Laboratories' Share-based Compensation amounted to $1.1 million in Q3 2025, which was down 1027.95% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Share-based Compensation peaked at $1.3 million during Q2 2025, and registered a low of $1.1 million during Q3 2025.